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Abstract—The current trend in X-ray radiotherapy is to treat
cancers that are in difficult locations in the body using beams
with a complex intensity profile. Intensity-modulated radiother-
apy (IMRT) is a treatment which improves the dose distribution
to the tumor whilst reducing the dose to healthy tissue. Such
treatments administer a larger dose per treatment fraction and
hence require more complex methods to verify the accuracy of
the treatment delivery. Measuring beam intensity fluctuations is
difficult as the beam is heavily distorted after leaving the patient
and transmission detectors will attenuate the beam and change
the energy spectrum of the beam. Monolithic active pixel sensors
(MAPSs) are ideal solid-state detectors to measure the 2-D beam
profile of a radiotherapy beam upstream of the patient. MAPS
sensors can be made very thin (∼30 µm) with still very good
signal-to-noise performance. This means that the beam would
pass through the sensor virtually undisturbed (<1% attenua-
tion). Pixel pitches of between 2 µm to 100 µm are commercially
available. Large area devices (∼15×15 cm2) have been produced.
MAPS can be made radiation hard enough to be fully functional
after a large number of fractions. All this makes MAPS a very
realistic transmission detector candidate for beam monitoring
upstream of the patient. A remaining challenge for thin, upstream
sensors is that the detectors are sensitive to the signal of both
therapeutic photons and electron contamination. Here, a method
is presented to distinguish between the signal due to electrons
and photons and thus provide real-time dosimetric information
in very thin sensors that does not require Monte Carlo simulation
of each linear accelerator treatment head.
Index Terms—Clinical/preclinical evaluation/application stud-
ies, dosimetry for radiation-based medical applications, mono-
lithic active pixel sensors (MAPSs), Monte Carlo simulations for
imaging and therapy, radiation detectors for medical applica-
tions, radiotherapy verification.
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I. INTRODUCTION
RADIOTHERAPY is one of the most prevalent treatmentsfor cancer, where 40% of cured cancers used radio-
therapy treatments in the U.K. [1]. It has been shown that
delivering shorter, more intense treatments with megavoltage
photon beams, improves the chances of treatment success [2].
Hence, this treatment strategy has seen increasing use in recent
years, with the added advantages of reducing the number of
times each patient must visit, and reducing National Health
Service (NHS) waiting times for radiotherapy treatments. The
use of higher dose rates has been made possible through the
increased treatment precision afforded by intensity-modulated
radiotherapy (IMRT) and volumetric modulated arc therapy
(VMAT). These modalities treat cancers that are in difficult
locations in the body using megavoltage photon beams with a
complex intensity profile. IMRT treatments deliver the radia-
tion from multiple angles with static or dynamic fields shaped
by (up to 160) leaves of the multileaf collimator (MLC). In
VMAT treatments the MLC leaves are dynamically moved
while the gantry rotates around the patient. The higher inten-
sity of these treatments means they pose a greater risk to the
patient should the machine deviate from the treatment plan.
With many moving mechanical parts, tracking them to ensure
they are in the right position is an additional safety measure,
external to the linear accelerator’s (linac) own systems, to
verify that the treatment is being performed correctly. This
real-time treatment monitoring is known as in-vivo dosimetry.
In-vivo dosimetry can be performed before or after the beam
has passed through the patient. Measuring the beam after it
has passed through the patient has the advantage of showing
the patient alignment with the treatment beam. However, mea-
suring beam intensity fluctuations downstream of the patient is
difficult as the beam is heavily distorted. Transmission detec-
tors are positioned upstream of the patient, sampling the beam
before it is scattered in the patient’s body. Hence, they can
measure MLC positions with a higher precision. The signal
response is composed of the therapeutic photons and elec-
trons generated predominantly by Compton scattering in the
flattening filter and collimators in the linac head, as well as in
the air. For a 6-MV linac the photon spectrum peaks at around
2 MeV with ∼ 60% of photons having energies between 1 and
3 MeV. The electron contamination spectrum contains ∼ 20%
of electrons with energy between 0.1 and 0.5 MeV and ∼ 75%
with <2 MeV. In order to extract dose information, trans-
mission detectors conventionally use a thick converter layer
to generate signal from Compton scattering of the photon
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Fig. 1. Schematic cross section of a MAPS (left) and the in-pixel circuitry of
a standard 3T MAPS device (right). The P++ substrate layer can be thinned
to < 10 µm.
beam. The large signal generated from the photons renders
any signal contamination from electrons generated in the head
of linac/in the air, negligible by comparison. Hence, the dose
to the patient can be derived from the measured photon signal
in these devices by using a treatment planning system [3]–[7].
However, these detectors attenuate the beam and change its
energy spectrum. Modeling a transmission device in the treat-
ment planning system is complex whilst modeling with Monte
Carlo is difficult, with long computing times [8]. The cur-
rent devices on the market, ScandiDos Delta4 discover [9], a
solid-state detector, and the Dolphin [10], an ionization cham-
ber system, have beam attenuations of 1.71% ± 0.02% and
∼ 10% at 6 MV, respectively. The DAVID sensor is a flat
plate ionization chamber which has signal readout wires posi-
tioned under each MLC leaf edge. The device specification
is, therefore, customized for different types of MLC. The
build-up material required to create a sufficiently measurable
signal for MLC edge detection produces a beam attenuation
of 4.7% ± 0.001% [11] at 6 MV. The IQM is a large area
position-sensitive ion chamber device, which has an attenu-
ation of 5.43%±0.02% at 6 MV [12]. In this article, a new
approach to dosimetry is presented, in which no additional
conversion layer is used, resulting in a beam attenuation below
1% [13], which is required by clinicians for real-time monitor-
ing devices to be used in a clinical setting without additional
calibrations in the treatment planning system.
A. Monolithic Active Pixel Sensor
We have been developing live treatment monitoring using
a monolithic active pixel sensors (MAPSs) [14] system.
Clinically, this device would be mounted on the linac treat-
ment head. MAPS have the sensor matrix and pixel readout
integrated into a single silicon wafer. These sensors are ideal
as they can be made very thin while maintaining a good
ratio of signal to noise and have negligible impact on the
beam, attenuating the photon beam by less than 1% [13]. A
schematic drawing of a three transistor (3T) MAPS sensor is
shown in Fig. 1. When a charged particle traverses the sensor,
electron—hole pairs are generated. The generated electrons
are confined in the potential well between the lightly doped
epitaxial layer and the highly doped substrate. No external
bias voltage is applied. The electrons diffuse through the epi-
taxial layer until they reach the depleted zone underneath the
Fig. 2. Compton scattering of a photon in the epitaxial layer (1, 2), in the
air/linac (3), and in the grating etched in the bulk (4).
diode. Here, the electrons are collected. The amount of col-
lected electrons affects the gate voltage of the source follower
and hence affects the current when the select switch is opened.
The top layer that houses the transistors is less than a micron
thick. The epitaxial layer, the layer where signal generation
takes place, is typically between ∼2 and ∼20-µm thick. The
first couple of microns of the substrate layer are needed to
create the built-in potential difference. The rest is only used
for mechanical support.
Hence, the device can be made less than ∼30 µm thick,
without loss of signal-to-noise, by thinning the device from
the back. This means that the beam would pass through the
sensor almost undisturbed (<<1% attenuation). Of course, an
extremely thin sensor, used without any conversion material
will be more significantly affected by the presence of the con-
tamination electrons compared to the signal photons. Hence,
in this article, a method is proposed to separate the electron
and photons signals, allowing the photon fluence to be deter-
mined. This article has centered around the Achilles 3T MAPS
sensor [15] which is ∼5 × 5 cm2 with a total thickness of
100 µm. It has 4096 × 4096 square pixels with a pitch of
14 µm. Radiation damage studies have shown that the Achilles
remained operational when tested with up to 300 million
electrons per pixel [15]. This equates to approximately 20-K
treatment fractions (at 2 Gy per fraction). Typically around
12-K treatment fractions are delivered per year in a radiother-
apy suite. We have previously shown with the Achilles sensor
mounted on the linac head, that we can achieve a leaf edge
resolution of 52±4 µm at the isocenter for leaves with a width
of 1 cm using 0.1 s of data taken at 400 MU/min for static
fields [16]. We have also shown that it is possible to monitor
dynamic treatments with continuously moving leaves [13].
II. METHOD : PATTERNING THE SENSOR
For dosimetry it is essential to only measure the signal due
to incoming photons as they will deposit the dose in the tumor.
A method was developed to separate the photon and electron
signal by exploiting the Compton scattering in the nonsensitive
bulk layer of the MAPS. With the beam incident on the back-
side of the sensor, it will traverse the bulk before the epitaxial
layer (back-illuminating). The number of electrons produced
by Compton scattering of the photons can be modulated by
changing the thickness of the bulk layer [see (4a) and (4b)
BECK et al.: NOVEL APPROACH TO CONTAMINATION SUPPRESSION IN TRANSMISSION DETECTORS FOR RADIOTHERAPY 639
Fig. 3. Schematic of the grating placed face down on the front-side of the
Achilles.
Fig. 4. Response from the MAPS sensor where the presence of the photon
field upon the strips is evident. The region of interest used for further study
is indicated. There is some signal saturation in defective rows of the sensor
in this prototype device.
in Fig. 2] [17]. The simplest approach is to etch strips into
the bulk layer of the MAPS. This does not alter the number
of Compton electrons generated by photons in the epitaxial
layer (1 and 2) or air (3). However, it does lead to an increase
of Compton electrons in the strips compared to the thin area;
comparing (4b) with (4a). For a sufficiently thin bulk layer,
the signal from contamination electrons (3) will have a neg-
ligible difference between peaks and troughs of the grating.
Hence, the photon contribution can be deduced by comparing
the signal from under a strip or under a trench.
III. EXPERIMENTAL
As a proof-of-principle study, a piece of 300-µm thick sil-
icon, etched with 50-µm deep trenches, was placed on top
of the MAPS as an alternative to etching the sensor directly.
The grating pattern formed from the etching was placed face
down on the sensor, as shown in Fig. 3. This was to minimize
the amount of scattering through extra material if the grating
were placed face up, which would make the pattern more dif-
fuse before reaching the epitaxial layer. A number of square
field sizes were delivered using an ElektaTM AgilityTM linac:
3 × 3 cm2, 4 × 4 cm2, 5 × 5 cm2, 6 × 6 cm2, and 7 × 7 cm2
at the isocenter. Fields are shaped using the MLC and Y-jaws.
Fig. 4 shows the enhanced signal where the 3 × 3 cm2 6-MV
photon beam is incident upon the MAPS sensor, which was
placed at the isocenter.
The 2-D sensor output is projected in 1-D along the grat-
ing, across 400 columns, clearly showing the modulation of
the photon contribution as shown in Fig. 5. It was first checked
that the pitch of the gratings obtained from the analysis was
Fig. 5. Profile of signal response perpendicular to the gratings. Inset: Fitted
data for a 7 × 7 cm2 field.
Fig. 6. Signal peak height extracted from the amplitude of the fitted sinusoidal
wave inside the photon field, outside the photon field and the addition of the
two.
consistent with the pitch known to be etched into the silicon. A
fit was made in the region of interest (shown on Fig. 4) of the
sensor where the photon field is present. A second-order poly-
nomial was fitted, to account for the background shape of the
field. A sinusoidal wave was used as a simple approximation
for small strip pitches to fit the periodic pattern caused by the
grating. The grating pitch was found to be 398.8 ± 0.2 µm
for all the field sizes, whilst the true pitch is known to be
400 ± 10 µm. An example of the fit overlaid on the data is
shown in Fig. 5 (inset).
The additional photon contribution due to the grating should
be proportional to the amplitude of the fitted sinusoidal wave
and independent of field size. Fig. 6 shows the peak height
over the background baseline shape for a range of field sizes.
Projections along the grating were taken across 400 columns
inside the field and 400 columns outside the field. A sen-
sor area was defined outside the field at least 1 cm from the
photon field edge. It can be seen that within the photon field
the peak height decreases with increasing field size. This is
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Fig. 7. Signal modulation predominantly from photons inside the photon
field. Outside the field modulation is mainly due to electron scattering in the
strips.
because the contamination electron background increases with
field size [18], with an anti-phase signal response primarily
due to scattering out of the sides of the peaks into the epi-
taxial layer below the troughs of the grating. The stopping of
low energy electrons does not have a significant impact on the
signal response as higher energy electrons lose energy through
the grating and compensate for this. Fig. 7 shows the signal
response inside the photon field and outside the photon field
along the same strips. Outside the photon field only the dif-
fuse contamination electron background contributes. It can be
seen that the signals are out of phase and thus the apparent
amplitude is lower. The peak height over baseline outside of
the field is also shown as a function of field size in Fig. 6
and as expected the amplitude of the electron signal is also
proportional to the field size, reflecting the increase in the
electron background. The electron background was measured
at the same point on the detector, outside of all the measured
fields. Therefore, it will not exactly represent the electron con-
tamination at the point measured inside the photon field as the
intensity of the electron contamination varies across its field.
It is only shown as a proof-of-principle concept. Hence, the
sum of the two contributions is approximately flat across dif-
ferent field sizes, denoted as “addition” in Fig. 6. This shows
that the peak height signal due to the photons themselves is
constant as a function of the field size and that if the elec-
tron contamination signal is removed, the signal modulation
will be representative of the photon fluence. The difference
between the peak and trough regions was 50 µm. To mitigate
against the modulation of the signal from electron contami-
nation, the grating can be made a combination of thinner and
wider such that, regions under the middle of peaks and troughs
can be identified where the scattering of electrons out of the
sides of the peaks does not have an impact. Note by chang-
ing the grating geometry such that the electron contamination
background has a constant flat signal response means there
is no need to measure the electron contamination outside of
the field. Thus, the signal will only significantly modulate due
to the increased Compton scattering under the peaks and the
photon fluence can be extracted.
Fig. 8. Profiles taken for a 5×5 cm2 field, integrated across 400 columns of
the sensor with the linac beam incident upon a 2-mm pitch grating structure.
Fig. 9. Linac was modeled simply as a Tungsten box with an opening that
projects to specified field sizes at isocenter. The position of the MAPS detector
and the phase space plane used, are indicated.
IV. ALTERNATIVE GRATING SIZE
A 2-mm pitch grating was also tested and a profile taken
across 400 columns is shown in Fig. 8 for a 5 × 5 cm2 field
size. It can be seen that the wider pitch means that the signal
can plateau in the peaks and troughs and may be preferable
for subtracting a constant electron background in the plateaued
regions. Out of field measurements were not possible in this
experiment as this grating structure was larger than the field
sizes tested. This will be the work of future studies. The
optimal grating pitch determines the granularity of dosime-
try and will depend on the angular spread of the scattered
electrons due to the difference in thickness between the peaks
and troughs.
V. SIMULATION
To confirm the experimental results, a simulation study was
performed using Gate [19], which is a software package based
on Geant4 [20], developed for use in studies of medical imag-
ing and radiotherapy. Simulations for generating the electron
contamination were particularly computationally intensive and
required 1013 initial photons to be simulated for the 3×3 cm2
field and the number of photons was proportionally scaled for
larger field sizes to maintain the same number of photons per
unit area. Hence, the simulations were distributed across ten
64-core AMD EPYC bare metal compute nodes using Oracle
cloud infrastructure [21]. The compute nodes were created
using an on-demand elastic cluster using the cluster in the
cloud system [22]. The isotropic cone beam of photons with
energies derived from the Mohan energy spectrum [23] was
propagated from the point where the target would be posi-
tioned inside the linac treatment head, as shown in Fig. 9. The
full linac head was not simulated as the purpose of this article
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Fig. 10. Gratings of 300-µm thickness and trench depth of 50-µm face down
on the epitaxial layer of the sensor. The beam is coming from right to left.
was to show that any beam consisting of electrons and photons
can be separated into its individual particle type components,
rather than needing to simulate the specific beam from a par-
ticular treatment head. Jaw collimators were simulated as 8-cm
thick blocks of Tungsten to shape the beam into field sizes of
3×3 cm2, 5×5 cm2, 7×7 cm2, and 10×10 cm2 as projected
at the isocenter. The electron contamination from the collima-
tors and ionization chamber were omitted as this contribution
is highly diffuse and occupies only 0.1% of the solid angle at
isocenter, where the measurements were taken and the sensor
was simulated at a source-surface distance (SSD) of 100 cm.
The simulated silicon strip structure has a 2-mm pitch, i.e.,
1-mm trench width and 1-mm peak width as used for Fig. 8.
The grating is 300-µm thick with a trench depth of 50 µm
and is placed face down on the epitaxial layer of the sensor.
Only a small area is simulated to save time, for the grating it is
13-mm wide, consisting of seven peaks and six trenches, and
10-mm long. It sits on top of a 17-mm wide and 12-mm long
subset of the sensor, such that there is a periphery around the
grating where the sensor is exposed to the beam with no grat-
ing present. The Achilles sensor is replicated with a 10-µm
epitaxial layer and total thickness of 100 µm. Energy deposits
are saved in 14 × 14 µm voxels to simulate the Achilles pix-
els. The Geant4 electromagnetic physics list emstandard_opt3
was used for its higher accuracy in electron tracking [20] and
Urbán model of multiple scattering [24]. A step limit of 3 µm
was set for electrons, positrons, and photons passing through
the grating and epitaxial layer of the sensor. Decreasing the
step limit further had no impact on the results and increased
compute time. Particles incident on the sides or back of the
linac head were killed to save compute time. The beam was
propagated through an air-filled world until just before the
grating and sensor, where the photons and electrons were saved
separately into phase space files.
The therapeutic photon and contamination electron contribu-
tions could then be separately propagated through the grating
and sensor, as shown in Fig. 10. The phase space file was
rotated by 90 degrees and recycled three more times.
The energy deposited in the epitaxial layer is shown in
Fig. 11 for photons and Fig. 12 for electrons. The energy
deposits are summed across 100 pixel columns for 1010
incident photons per cm2.
Fig. 11. Simulation output of the energy deposited in the epitaxial layers
for photons only, after passing through the grating.
Fig. 12. Simulation output of the energy deposited in the epitaxial layers
for electrons only, after passing through the grating.
In Fig. 11 it can quite clearly be seen that the photon signal
is independent of field size and that the grating pattern is very
evident. There is an enhancement of the signal where the seven
peaks are located above the six trench areas.
In Fig. 12 it can be seen that the energy deposited by con-
tamination electrons in the sensor increases with increasing
field size. Furthermore it can be seen that the pattern is anti-
phase to that shown in Fig. 11, confirming the experimental
findings in Fig. 7. It should be noted that in Figs. 11 and 12 the
total energy deposited in the silicon is shown, as opposed to the
analogue-to-digital converted (ADC) units read out from the
sensor. Hence, charge sharing between pixels is not accounted
for. It is apparent from the dips in signal at the edge of the
supplementary piece of the patterned silicon at ±6.25 mm and
subsequent increase in signal immediately outside of the grat-
ing, that the shape of the peaks is also influenced by a larger
amount of electron scattering out of the thicker strips of the
grating than in the thinner strips.
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Fig. 13. Schematic of incident beam angles on the 4-mm pitch grating.
Fig. 14. Normalized simulated energy deposit in the epitaxial layer from an
electron beam incident at 0, 20, and −30 degrees for a 4-mm pitch grating.
There are three troughs, one of which is in the centred at 0, and 4 peaks.
A. Toward Deployable Grating Structure
The experimental results presented in this article show that
the concept of a grating can indeed be used to extract the sig-
nal by photons after correcting the total signal for the signal
deposited by electrons. For a deployable device, it is key that
the electron signal is constant throughout the detector such
that the signal is modulated by the photons only. This can be
achieved by making the grating thin and wide enough. For a
grating structure with a 4-mm pitch (2-mm trench and 2-mm
peak width) with the same thickness as our experimental grat-
ing three simulations were produced with electrons incident
on the grating at 0, 20, and −30 degrees, as indicated in
Fig. 13. The electron energy spectrum was taken from the
previously mentioned simulation. In Fig. 14 the simulated
deposited energy by the electrons in the epitaxial layer across
100 pixel columns is shown. Each distribution has been nor-
malized to the average signal under the middle ten pixels of
the peaks and troughs so the scattering patterns can be seen
with respect to the incoming electron angle. Besides the spikes
at the grating edges, the signal due to electrons is essentially
flat. Hence, it is apparent that the anti-phase pattern is due
to the scattering from the thicker peak sections of the grat-
ing into the air gap under the troughs. This shows that for an
appropriately designed grating structure, there is no need to
measure the electron signal outside the field as the signal from
the pixel region under the middle of the peaks and troughs
can be used, avoiding the scattering at the sides. Hence, only
the photon signal will be causing a modulation in the sen-
sor response, and thus the photon fluence and subsequently
the dose information, can be extracted directly. A study to
determine the optimal dimensions of the grating is currently
in progress.
VI. DISCUSSION
In order to obtain the dose received by a patient, only signals
generated by photons are required. Contamination electrons
generated in the linac head and air also generate signal in
MAPS sensors. Despite the lower flux of contamination elec-
trons their contribution to the total signal is larger than that
deposited by the photons due to the much larger interaction
cross section of electrons with silicon. In this article, we
have shown that the signals generated in MAPS from elec-
tron contamination and therapeutic photons are dependent on
the thickness of material traversed before the epitaxial layer in
the sensor. This can be achieved by patterning the bulk layer of
the MAPS with strips and back-illuminating the sensor to the
beam such that the beam will traverse the pattern before the
epitaxial layer. If the bulk is made sufficiently thin [O(50 µm)]
then the electron signal will be relatively flat compared to the
modulated photon signal, with the added advantage of having
<1% beam attenuation, which clinicians require for real-time
monitoring devices to be accepted into clinical use without
additional calibrations. The signal modulation observed exper-
imentally was confirmed in simulation using the Mohan energy
spectrum for a 6-MV photon spectrum and the contamination
electrons generated in the air and linac jaws from those pho-
tons. In future iterations of the simulation, the sensor will
be modeled at the linac head. Then it will be necessary to
include contamination electrons from the other components of
the linac head, such as the flattening filter, where the angular
and spatial distribution will differ from that at the isocenter.
Further experiments will be performed on different topologies
of the grating structure, including much thinner gratings. It
has been shown that the electron contamination reduces with
distance from the linac head [25], [26], hence in the future
we will include studies at different SSDs. The trench dimen-
sions and overall thickness of the grating will be optimized
to minimize the contribution from contamination electrons to
the modulation total signal, allowing the photon signal to be
extracted. After this, we will determine a mapping between
the 2-D photon signal generated in the sensor and a 3-D dose
profile as has been shown for the Magic Plate [7] and Octavius
4D [27].
VII. CONCLUSION
It is necessary to develop new techniques to monitor the
increasingly complex IMRT treatments being used for target-
ing cancerous tumors. MAPSs are highly appropriate devices
for real-time upstream dose monitoring due to their <1%
beam attenuation at 6 MV. They also have an excellent posi-
tion resolution of 52 ± 4 µm at the isocenter for leaves
with a width of 1 cm using 0.1 s of data for static fields.
Producing a pattern of strips into the nonactive bulk layer of
the back-illuminated sensor has been shown to be a success-
ful method of distinguishing the contributions of therapeutic
photons and contamination electrons and the phenomenon has
been confirmed in simulation. This will allow the dose to the
patient to be accurately obtained in realtime without relying
on Monte Carlo simulation of each individual linac treatment
head.
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